Lesinurad Sodium - CAS# 1151516-14-1 BL0137 Nawrocki ST

Nawrocki ST

SD70 was found to inhibit the androgen-dependent AR program and prostate cancer cell growth

decreases ERK phosphorylation

1-7H3/t16-

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

Lesinurad Sodium - CAS# 1151516-14-1 BL0137 Nawrocki STLesinurad, also known as RDEA594, is a selective uric acid re absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body. RDEA594 has been shown to normalize the amount of uric acid excreted by gout patients previously classified as under excretors. Lesinurad received FDA approval on December 22, 2015. Product information CAS Number: 1151516 14 1 Molecular